HC Wainwright Reaffirms “Buy” Rating for Repare Therapeutics (NASDAQ:RPTX)
HC Wainwright reissued their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) in a research note published on Thursday morning, Benzinga reports. The firm currently has a $10.00 price target on the stock. Separately, Bloom Burton upgraded Repare Therapeutics from an accumulate rating to a buy rating in a report on Friday, […]
More Stories
CVS Health (NYSE:CVS) Raised to Buy at TD Cowen
TD Cowen upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a buy rating in...
Barclays Trims Devon Energy (NYSE:DVN) Target Price to $46.00
Devon Energy (NYSE:DVN – Free Report) had its price objective decreased by Barclays from $55.00 to $46.00 in a report...
Digital Realty Trust (NYSE:DLR) Upgraded at HSBC
HSBC upgraded shares of Digital Realty Trust (NYSE:DLR – Free Report) from a reduce rating to a hold rating in...
Lloyds Banking Group (NYSE:LYG) Receives New Coverage from Analysts at The Goldman Sachs Group
The Goldman Sachs Group started coverage on shares of Lloyds Banking Group (NYSE:LYG – Free Report) in a research report...
argenx (NASDAQ:ARGX) Downgraded by Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft downgraded shares of argenx (NASDAQ:ARGX – Free Report) from a buy rating to a hold rating in...
Amazon.com (NASDAQ:AMZN) Receives Overweight Rating from Morgan Stanley
Morgan Stanley reissued their overweight rating on shares of Amazon.com (NASDAQ:AMZN) in a research report sent to investors on Thursday...